Differential effect of corticotropin releasing factor on interleukin-1 alpha and interleukin-1 beta-induced prostaglandin synthesis in endothelial cells and fibroblasts.
Fleisher-Berkovich
S
S
Department of Clinical Pharmacology, Corob Center of Health Sciences, Ben-Gurion University and Soroka Medical Center, Beer-Sheva, Israel.
Danon
A
A
D015121:6-Ketoprostaglandin F1 alpha / Q000096:biosynthesis; D000818:Animals; D001011:Aorta; D001095:Arachidonic Acids / Q000378:metabolism; D002417:Cattle; D002478:Cells, Cultured; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology*; D015232:Dinoprostone / Q000096:biosynthesis; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D011453:Prostaglandins / Q000096:biosynthesis*; D012867:Skin / Q000187:drug effects / Q000378:metabolism*
D001095:Arachidonic Acids; D007375:Interleukin-1; D011453:Prostaglandins; D015121:6-Ketoprostaglandin F1 alpha; D003346:Corticotropin-Releasing Hormone; D011451:Prostaglandin-Endoperoxide Synthases; D015232:Dinoprostone